RA Capital Management

Ra Capital Management as of March 31, 2024

Portfolio Holdings for Ra Capital Management

Ra Capital Management holds 75 positions in its portfolio as reported in the March 2024 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Ascendis Pharma A/s - SH (ASND) 19.6 $1.5B 10M 151.17
Vaxcyte SH (PCVX) 7.2 $560M 8.2M 68.31
Legend Biotech Corp- SH (LEGN) 4.9 $385M 6.9M 56.09
Janux Therapeutics SH (JANX) 4.4 $345M 9.2M 37.65
Aerovate Therapeutics SH (AVTE) 3.1 $244M 8.3M 29.57
Rhythm Pharmaceuticals SH (RYTM) 3.0 $231M 5.3M 43.33
Evolent Health Inc - A SH (EVH) 2.4 $188M 5.7M 32.79
Newamsterdam Pharma Co Nv SH (NAMS) 2.4 $186M 7.9M 23.65
Rxsight SH (RXST) 2.3 $178M 3.4M 51.58
Tyra Biosciences SH (TYRA) 2.2 $171M 10M 16.40
Edgewise Therapeutics SH (EWTX) 2.1 $163M 8.9M 18.24
4d Molecular Therapeutics In SH (FDMT) 2.1 $161M 5.1M 31.86
Biogen SH (BIIB) 2.0 $160M 741k 215.63
Pepgen SH (PEPG) 2.0 $157M 11M 14.70
Geron Corp SH (GERN) 2.0 $153M 46M 3.30
89bio SH (ETNB) 1.9 $149M 13M 11.64
Dyne Therapeutics SH (DYN) 1.8 $141M 5.0M 28.39
Apogee Therapeutics SH (APGE) 1.7 $131M 2.0M 66.45
Day One Biopharmaceuticals I SH (DAWN) 1.7 $129M 7.8M 16.52
Nkarta SH (NKTX) 1.5 $117M 11M 10.81
Wave Life Sciences SH (WVE) 1.4 $112M 18M 6.17
Ars Pharmaceuticals SH (SPRY) 1.4 $111M 11M 10.22
Fulcrum Therapeutics SH (FULC) 1.4 $110M 12M 9.44
Verona Pharma Plc - SH (VRNA) 1.3 $102M 6.3M 16.09
Lenz Therapeutics SH (LENZ) 1.2 $93M 4.2M 22.33
Inhibrx SH 1.2 $92M 2.6M 34.96
Avidity Biosciences SH (RNA) 1.1 $84M 3.3M 25.52
Axsome Therapeutics SH (AXSM) 1.0 $80M 1.0M 79.80
Longboard Pharmaceuticals In SH (LBPH) 0.9 $71M 3.3M 21.60
Dianthus Therapeutics SH (DNTH) 0.9 $70M 2.3M 30.00
Gh Research SH (GHRS) 0.9 $67M 6.3M 10.66
Structure Therapeutics SH (GPCR) 0.8 $65M 1.5M 42.86
Mineralys Therapeutics SH (MLYS) 0.8 $63M 4.9M 12.91
Astria Therapeutics SH (ATXS) 0.8 $62M 4.4M 14.07
Acumen Pharmaceuticals SH (ABOS) 0.8 $61M 15M 4.05
Iteos Therapeutics SH (ITOS) 0.8 $60M 4.4M 13.64
Solid Biosciences SH (SLDB) 0.7 $58M 4.3M 13.32
Madrigal Pharmaceuticals SH (MDGL) 0.7 $55M 205k 267.04
Vor Biopharma SH (VOR) 0.7 $54M 23M 2.37
Praxis Precision Medicines I SH (PRAX) 0.6 $51M 828k 61.02
Urogen Pharma SH (URGN) 0.6 $46M 3.1M 15.00
Larimar Therapeutics SH (LRMR) 0.6 $46M 6.0M 7.59
Cytek Biosciences SH (CTKB) 0.6 $46M 6.8M 6.71
C4 Therapeutics SH (CCCC) 0.5 $40M 4.9M 8.17
Werewolf Therapeutics SH (HOWL) 0.5 $40M 6.1M 6.48
Enliven Therapeutics SH (ELVN) 0.5 $37M 2.1M 17.59
Eliem Therapeutics SH (ELYM) 0.5 $36M 13M 2.74
Acrivon Therapeutics SH (ACRV) 0.4 $34M 4.8M 7.15
Taysha Gene Therapies SH (TSHA) 0.4 $31M 11M 2.87
Boundless Bio SH (BOLD) 0.4 $31M 2.2M 14.25
Macrogenics SH (MGNX) 0.4 $31M 2.1M 14.72
Tenaya Therapeutics SH (TNYA) 0.4 $30M 5.8M 5.23
Cybin SH (CYBN) 0.3 $24M 58M 0.41
Alto Neuroscience SH (ANRO) 0.3 $21M 1.4M 15.35
Cervomed SH (CRVO) 0.3 $20M 862k 23.30
Vaxart SH (VXRT) 0.3 $20M 15M 1.30
Bicycle Therapeutics Plc- SH (BCYC) 0.3 $20M 800k 24.90
Eyepoint Pharmaceuticals SH (EYPT) 0.2 $19M 939k 20.67
Third Harmonic Bio SH (THRD) 0.2 $19M 2.0M 9.44
Pliant Therapeutics SH (PLRX) 0.2 $19M 1.3M 14.90
Sera Prognostics Inc-a SH (SERA) 0.2 $18M 2.0M 9.10
Metagenomi SH (MGX) 0.2 $18M 1.7M 10.55
Immatics Nv SH (IMTX) 0.2 $18M 1.8M 10.51
An2 Therapeutics SH (ANTX) 0.2 $18M 5.6M 3.25
Regulus Therapeutics SH (RGLS) 0.2 $18M 6.3M 2.88
Black Diamond Therapeutics I SH (BDTX) 0.2 $18M 3.5M 5.07
Adicet Bio SH (ACET) 0.2 $18M 7.5M 2.35
Arvinas SH (ARVN) 0.2 $17M 421k 41.28
Lexeo Therapeutics SH (LXEO) 0.1 $10M 661k 15.68
Chimerix SH (CMRX) 0.1 $9.3M 8.8M 1.06
Igm Biosciences SH (IGMS) 0.1 $9.0M 938k 9.65
Compass Pathways SH (CMPS) 0.1 $6.6M 791k 8.32
Curevac Nv SH (CVAC) 0.1 $6.0M 2.0M 3.03
Unicycive Therapeutics SH (UNCY) 0.1 $4.8M 3.5M 1.38
Newamsterdam Pharma Co Nv-27 SH (NAMSW) 0.0 $3.7M 333k 11.04